Insulin Market Size, Share & Trends Analysis By Product Type (Rapid-Acting Insulin, Long-Acting Insulin, Combination Insulin, Biosimilar), By Application, By Type (Type 1, Type 2), By Distribution Channel- Global Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2022-2030
Chapter 1 Methodology and Scope
1.1 Market segmentation
1.1.1 Estimates and forecast timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased database
1.3.2 Nova one advisor’S internal database
1.3.3 Secondary sources
1.3.4 Primary research
1.3.5 Details of primary research
1.3.6 List of primary sources
1.4 Information or data analysis
1.4.1 Data analysis models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity flow analysis
1.6.1.1 Approach 1: Commodity Flow Approach
1.6.1.2 Approach 2: Country-wise market estimation using the bottom-up approach
1.7 Global Market: CAGR Calculation
1.8 Research Assumptions
1.9 List of Secondary Sources
1.10 List of Abbreviations
1.11 Objectives
1.11.1 Objective 1
1.11.2 Objective 2
1.11.3 Objective 3
1.11.4 Objective 4
Chapter 2 Executive Summary
2.1 Market Summary
Chapter 3 Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent market outlook
3.2 Regulatory framework
3.3 Penetration and Growth Prospect Mapping
3.4 Pipeline Analysis
3.5 Market Dynamics
3.5.1 Market driver analysis
3.5.1.1 Increase in prevalence of diabetes
3.5.1.2 Increase in geriatric and obese population
3.5.1.3 Formulation advancements in insulin delivery systems
3.5.2 Market restraint analysis
3.5.2.1 High cost of insulin
3.5.2.2 Poor reimbursement policies
3.5.2.3 Launch of insulin biosimilars and increasing penetration of glp-1 agonists
3.6 Porter's Five Forces Analysis
3.7 PESTEL Analysis
3.8 COVID-19 Impact
Chapter 4 Global Insulin Market - Segment Analysis, By Product Type, 2018 - 2030 (USD Million)
4.1 Global Insulin Market: Product Type Movement Analysis
4.2 Rapid-Acting Insulin
4.2.1 Rapid-acting insulin market estimates and forecast, 2018 - 2030 (USD Million)
4.3 Long-acting Insulin
4.3.1 Long-acting insulin market estimates and forecast, 2018 - 2030 (USD Million)
4.4 Combination Insulin
4.4.1 Combination insulin market estimates and forecast, 2018 - 2030 (USD Million)
4.5 Biosimilar
4.5.1 Biosimilar market estimates and forecast, 2018 - 2030 (USD Million)
4.6 Others
4.6.1 Other market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 5 Global Insulin Market - Segment Analysis, By Type, 2018 - 2030 (USD Million)
5.1 Global Insulin Market: Type Movement Analysis
5.2 Human Insulin
5.2.1 Human Insulin Market Estimates and Forecast, 2018 - 2030 (USD Million)
5.3 Insulin Analog
5.3.1 Insulin Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6 Global Insulin Market - Segment Analysis, Application, 2018 - 2030 (USD Million)
6.1 Global Insulin Market: Application Movement Analysis
6.2 Type 1 Diabetes Mellitus
6.2.1 Type 1 diabetes mellitus market estimates and forecast, 2018 - 2030 (USD Million)
6.3 Type 2 Diabetes Mellitus
6.3.1 Type 2 diabetes mellitus market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 7 Global Insulin Market - Segment Analysis, By Distribution Channel, 2018 - 2030 (USD Million)
7.1 Global Insulin Market: Distribution Channel Movement Analysis
7.2 Hospital Pharmacy
7.2.1 Hospital pharmacy market estimates and forecast, 2018 - 2030 (USD Million)
7.3 Retail Pharmacy
7.3.1 Retail pharmacy market estimates and forecast, 2018 - 2030 (USD Million)
7.4 Others
7.4.1 Other market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 8 Insulin Market: Segment Analysis, by region, 2018 - 2030 (USD Million)
8.1 Insulin Market: Regional Movement Analysis
8.1.1 North America
8.1.1.1 North America market estimates and forecast, 2018 - 2030 (USD Million)
8.1.1.2 U.S.
8.1.1.2.1 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
8.1.1.3 Canada
8.1.1.3.1 Canada market estimates and forecast, 2018 - 2030 (USD Million)
8.1.2 Europe
8.1.2.1 Europe market estimates and forecast, 2018 - 2030 (USD Million)
8.1.2.2 UK
8.1.2.2.1 UK market estimates and forecast, 2018 - 2030 (USD Million)
8.1.2.3 Germany
8.1.2.3.1 Germany market estimates and forecast, 2018 - 2030 (USD Million)
8.1.2.4 France
8.1.2.4.1 France market estimates and forecast, 2018 - 2030 (USD Million)
8.1.2.5 Spain
8.1.2.5.1 Spain market estimates and forecast, 2018 - 2030 (USD Million)
8.1.2.6 Italy
8.1.2.6.1 Italy market estimates and forecast, 2018 - 2030 (USD Million)
8.1.3 Asia Pacific
8.1.3.1 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
8.1.3.2 Japan
8.1.3.2.1 Japan market estimates and forecast, 2018 - 2030 (USD Million)
8.1.3.3 China
8.1.3.3.1 China market estimates and forecast, 2018 - 2030 (USD Million)
8.1.3.4 India
8.1.3.4.1 India market estimates and forecast, 2018 - 2030 (USD Million)
8.1.3.5 Australia
8.1.3.5.1 Australia market estimates and forecast, 2018 - 2030 (USD Million)
8.1.3.5 South Korea
8.1.3.5.1 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
8.1.4 Latin America
8.1.4.1 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
8.1.4.2 Brazil
8.1.4.2.1 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
8.1.4.3 Mexico
8.1.4.3.1 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
8.1.4.4 Argentina
8.1.4.4.1 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
8.1.5 Middle East & Africa
8.1.5.1 Middle East & Africa market estimates and forecast, 2018 - 2030 (USD Million)
8.1.5.2 South Africa
8.1.5.2.1 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
8.1.5.3 Saudi Arabia
8.1.5.3.1 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
8.1.5.5 United Arab Emirates
8.1.5.5.1 United Arab Emirates market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 9 Global Insulin Market: Competitive Analysis
9.1 Recent Developments and Impact Analysis, by Key Market Participants
9.1.1 Synergy analysis: major deals and strategic alliances
9.1.1.1 New Product Launches
9.1.1.2 Mergers and Acquisitions
9.1.1.3 Partnerships & Agreements
9.2 Company Categorization
9.2.1 Innovators
9.2.2 Market Leaders
9.2.3 Emerging Players
9.2.4 Heat Map Analysis
9.3 Company Market Position Analysis
9.4 Vendor Landscape
9.4.1 List of Key Distributors and Channel Partners
9.4.2 List of Potential End-Users
9.4.3 Key Company Market Share Analysis, 2021
9.5 Company Market Share/Ranking, 2021
9.5.1 Company Market Share/Ranking, Rapid-Acting Insulin, 2021
9.5.2 Company Market Share/Ranking, Long-Acting Insulin, 2021
9.5.3 Company Market Share/Ranking, Biosimilars, 2021
9.5.4 Company Market Share/Ranking, Others, 2021
9.5.5 Competitive Dashboard Analysis
9.6 Private Companies
9.6.1 List of Key Emerging Companies
9.6.2 Regional Network Map
9.7 Company Profiles
9.7.1 Eli Lilly and Company
9.7.1.1 Company overview
9.7.1.2 Financial performance
9.7.1.3 Product benchmarking
9.7.1.4 Strategic initiatives
9.7.2 Sanofi
9.7.2.1 Company overview
9.7.2.2 Financial performance
9.7.2.3 Product benchmarking
9.7.2.4 Strategic initiatives
9.7.3 Novo Nordisk A/S
9.7.3.1 Company overview
9.7.3.2 Financial performance
9.7.3.3 Product benchmarking
9.7.3.4 Strategic initiatives
9.7.4 Biocon
9.7.4.1 Company overview
9.7.4.2 Financial performance
9.7.4.3 Product benchmarking
9.7.4.4 Strategic initiatives
9.7.5 Boehringer Ingelheim International GmbH
9.7.5.1 Company overview
9.7.5.2 Financial performance
9.7.5.3 Product benchmarking
9.7.5.4 Strategic initiatives
9.7.6 Tonghua Dongbao Pharmaceutical Co. Ltd.
9.7.6.1 Company overview
9.7.6.2 Product benchmarking
9.7.6.3 Strategic initiatives
9.7.7 Wockhardt
9.7.7.1 Company overview
9.7.7.2 Financial performance
9.7.7.3 Product benchmarking
9.7.8 Julphar
9.7.8.1 Company overview
9.7.8.2 Financial performance
9.7.8.3 Product benchmarking
9.7.8.4 Strategic initiatives
9.7.9 The United Laboratories International Holdings Limited
9.7.9.1 Company overview
9.7.9.2 Financial performance
9.7.9.3 Product benchmarking